Find a Study

The ADD-ME roster holds names, health and contact information for people who may want to participate in Alzheimer’s Disease research.

ALZ-NET collects clinical and safety data about patients being evaluated for memory concerns or receiving new FDA-approved treatments for Alzheimer’s disease, including drugs/medications and devices, and tracks the long-term health outcomes associated with their use in real-world settings.

An oral medication, CT1812, is being investigated for the potential treatment of Dementia with Lewy Bodies (DLB). The purpose of this clinical trial is to learn about the safety of CT1812 and how well your body tolerates a once-a-day dose of CT1812.

DLBC is an observational research study aimed at learning more about Dementia with Lewy Bodies. The trial focuses on identifying biomarkers associated with the disease.

Duke University Medical Center School of Nursing is conducting research on the effect of music on sleep. The goal of this in-home research study is to introduce music that promotes healthy sleep and improves overall well-being in older adults with memory loss.

The Memory & Aging Study by the Duke-UNC Alzheimer’s Disease Research Center aims to pinpoint the biological factors related to both regular brain aging and diseased brain decline.

This is a Phase 1 clinical trial sponsored by Lilly, designed for individuals with mild cognitive impairment or mild Alzheimer’s disease. The study involves an investigational drug administered via injection into the spinal column, and aims to evaluate whether the treatment can reduce levels of tau protein.

The main purpose of this study is to evaluate the safety of LY3954068 in participants with early symptomatic Alzheimer’s Disease (AD).

The Registry is designed to increase awareness of Alzheimer’s disease and related dementias and to connect North Carolinians of all ages to research opportunities designed to improve brain health.